G. Resch

510 total citations
9 papers, 381 citations indexed

About

G. Resch is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, G. Resch has authored 9 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in G. Resch's work include Colorectal Cancer Treatments and Studies (4 papers), Antifungal resistance and susceptibility (2 papers) and Sepsis Diagnosis and Treatment (2 papers). G. Resch is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Antifungal resistance and susceptibility (2 papers) and Sepsis Diagnosis and Treatment (2 papers). G. Resch collaborates with scholars based in Austria, Switzerland and Germany. G. Resch's co-authors include Jutta Auberger, Cornelia Lass‐Flörl, Martin C. Freund, David Nachbaur, Astrid Mayr, Günther Gastl, Ralf Bialek, Hans Rabl, Wolfgang Eisterer and Alexander de Vries and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Radiotherapy and Oncology.

In The Last Decade

G. Resch

8 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Resch Austria 6 243 242 81 58 54 9 381
Hideki Ikeda Japan 9 81 0.3× 86 0.4× 20 0.2× 22 0.4× 6 0.1× 33 247
Anne Bignon France 6 110 0.5× 86 0.4× 55 0.7× 30 0.5× 4 0.1× 10 212
Shen Han China 9 179 0.7× 204 0.8× 6 0.1× 112 1.9× 4 0.1× 16 323
В. И. Симаненков Russia 9 40 0.2× 43 0.2× 27 0.3× 133 2.3× 7 0.1× 43 319
Minh-Vu H Nguyen United States 10 185 0.8× 150 0.6× 21 0.3× 40 0.7× 23 253
Michelle Bourne United Kingdom 9 193 0.8× 37 0.2× 7 0.1× 76 1.3× 8 0.1× 20 753
Ratna Sharma India 5 257 1.1× 122 0.5× 7 0.1× 7 0.1× 10 0.2× 6 335
Lindsey te Brake Netherlands 7 209 0.9× 132 0.5× 19 0.2× 170 2.9× 19 352
Catherine DeVoe United States 7 175 0.7× 89 0.4× 75 0.9× 14 0.2× 3 0.1× 13 275
Ceena Neena Jacob India 5 282 1.2× 78 0.3× 6 0.1× 13 0.2× 11 0.2× 7 334

Countries citing papers authored by G. Resch

Since Specialization
Citations

This map shows the geographic impact of G. Resch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Resch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Resch more than expected).

Fields of papers citing papers by G. Resch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Resch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Resch. The network helps show where G. Resch may publish in the future.

Co-authorship network of co-authors of G. Resch

This figure shows the co-authorship network connecting the top 25 collaborators of G. Resch. A scholar is included among the top collaborators of G. Resch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Resch. G. Resch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ambrosini‐Spaltro, Andrea, et al.. (2015). Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) and multiple pulmonary epithelioid hemangioendothelioma (PEH): a case report.. PubMed. 107(1). 37–42. 2 indexed citations
2.
Resch, G., Alexander de Vries, Dietmar Öfner, et al.. (2011). Preoperative treatment with capecitabine, bevacizumab and radiotherapy for primary locally advanced rectal cancer – A two stage phase II clinical trial. Radiotherapy and Oncology. 102(1). 10–13. 53 indexed citations
3.
Resch, G., et al.. (2011). Colorectal cancer in elderly patients: A single-center experience.. Journal of Clinical Oncology. 29(4_suppl). 576–576. 1 indexed citations
4.
Resch, G. & J. Thaler. (2011). Adjuvant chemotherapy in colon carcinoma stages II and III. memo - Magazine of European Medical Oncology. 4(2). 86–89.
5.
Frass, Michael, S. Banyai, G. Resch, et al.. (2011). Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy. 100(1-2). 95–100. 12 indexed citations
6.
Perkhofer, Susanne, Cornelia Lass‐Flörl, Michaela M. Hell, et al.. (2010). The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. International Journal of Antimicrobial Agents. 36(6). 531–536. 79 indexed citations
7.
Thalhammer, Florian, et al.. (2010). Analysis of the effects of vitamin K1 cream on cetuximab-induced acne-like rash.. Journal of Clinical Oncology. 28(15_suppl). e19671–e19671. 7 indexed citations
8.
Lass‐Flörl, Cornelia, G. Resch, David Nachbaur, et al.. (2007). The Value of Computed Tomography-Guided Percutaneous Lung Biopsy for Diagnosis of Invasive Fungal Infection in Immunocompromised Patients. Clinical Infectious Diseases. 45(7). e101–e104. 176 indexed citations
9.
Frass, Michael, S. Banyai, G. Resch, et al.. (2005). Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy. 94(2). 75–80. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026